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DJet restriction bas repeatedly been shown to reduce the 
incldence of spontaneous and chem.ically induced tumors in 
rodents. However, no conclus:ive data are avallable to show 
whether ca.rclnogenesfs by chronic exposure to a genotoxic 
agent can also be retarded. In this study, diet restriction to 
70% was lnvestigated for a protective effect on the formation 
of skin papilloma in male NMRI mlce treated twice weekly 
with 20 nmol 7,12-dimethylbenz[a]anthracene (DMBA). 
Rather surprisingly, no protection was seen. Both time of 
onset of papilloma formation (13 weeks in both groups) and 
time of 50% cumulative incldence {t50; 17.5 and 18 weeks) 
were similar in the unrestricted and the restricted group. In 
contrast, a clearly protective eft'ect was found in mice initiated 
with 100 nmol DMBA and promoted twice weekly with 2.5 
nmol U-0-tetradecanoylphorbol-13-acetate: the onset of 
papilloma formation increased from 7 to 11.5 weeks, the t50 
was shifted from 8.5 to 19 weeks. Diet restriction, therefore, 
was not protective under conditions of chronic exposure to 
a genotoxic carcinogen. lt cannot be considered a universal 
measure of cancer prevention. 
A large number of experimental studies have demonstrated that 
diet restriction markedly reduces both spontaneous and chemically 
induced tumor fonnation in mice and rats ( 1 - 17). A number 
of reviews are also available ( 18-21). Reports on experiments 
where restriction had no protective effect are rare ( 1 0). It 
therefore appears as if reduction of food intake could be regarded 
as a universal cancer-preventive measure. 
In the majority of the investigations on chemically induced 
tumor induction, the carcinogen was given as a single dose 
(10,12-14) or for up to 4 weeks (5,7,10,15). In few studies, 
the treatment with the carcinogen Iasted Ionger but was stopped 
either before the appearance of the first twnor (2-4) or when 
the first tumor appeared in the unrestricted group ( 1). It therefore 
remains to be shown whether the process of carcinogenesis can 
be retarded by diet restriction under conditions of chronic 
administration of a genotoxic agent. To answer this question, the 
skin twnor model with NMRI mice and chronic administration 
of7,12-dimethylbenz[a]anthracene (DMBA*) was used (22-24). 
Restrietion was by feed reduction to 70%, a Ievel chosenon the 
basis of the findings that underfeeding at a Ievel of 60% was 
well tolerated and indistinguishable from caloric (carbohydrate) 
restriction to 60% with respect to body weight and tumor 
incidence ( 16). 
Male NMRI mice [Crl:NMRI BR] were obtained from Charles 
River Savo, Kisslegg, Gennany, at 6 weeks of age. The mice 
• Abbrevladons: DMBA, 7, 12-di.mcthylbenz[a ]81'11hraceoe; TP A, 12-<J..tetra. 
decaooylphorbol-13-aa:tate; B[a l P, benzo[a ]pyrcne. 
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were housed individually at 21 ± 1 °C with a 12 h light/dark 
cycle in Macrolon cages type ll. Feed (Nafag 890 from Nafag 
AG, Gossau, Switzerland) and water were given ad libitum to 
all mice from 6 to 8 weeks of age. The backs of the mice were 
shaved at week 7 (a swatch 4 cm long, 3 cm wide; Wella 
Minicut). One week later, restriction and treatmentwas started. 
The restricted mice were given weighed feed portians amounting 
to 70% of the feed eaten by the unrestricted group. Every evening 
at 6.30 p.m., i.e. 30 m.in before the beginning ofthe dark phase, 
a rotaring wheel delivered the weighed portions into the feed 
compartment of the cages. The size of the portions was adjusted 
weekly on the basis ofthe weigbed feed intake by the unrestticted 
group. 
Treatment A (chronic administration of DMBA): starring at 
week 0, 60 mice (30 ad übitum, 30 restricted) received twice 
weekly a dermal application of 20 nmol DMBA (Sigma) in 0.1 
ml acetone on the shaved part of the back until 4 days before 
they were killed. Application solution was prepared biweekly and 
was stored at - 20°C. One mouse in each group died 
spontaneously during the experiment. Treatment B (initiation with 
DMBA, promotion with 12-0-tetradecanoylphorbol-13-acetate 
[TPA]; positive control for a protective effect of diet restriction): 
twenty-eight mice (14 ad libitum, 14 restricted) were treated once 
with 100 nmol DMBA in 0.1 ml acetone ( = week 0). Treatment 
with 2.5 nmol TPA (LC Services Corporation, Wobum, MA), 
twice weekly in 0.1 ml acetone, was started 1 week later. A TPA 
stock solution (8 x) was prepared once, divided into 5 ml aliquots 
and stored at -20°C. Two mice of the restricted group died 
spontaneously during the experiment. Controls: two groups of 
mice (9 ad libitum, 9 restricted) were treated twice weekly with 
0. 1 ml acetone. 
Allmice were visually inspected and palpated for papillomas 
twice weekly and were weighed biweekly. They were killed 2 
weeks after showing the first, persistent papilloma with diameter 
>1 mm. 
Body weights are given in Figure 1. Diet restriction resulted 
in a significant reduction in body weight under both treatments. 
In the initiation-promotion model (Figure 1 ; treatment B), the 
initial decrease appeared to be faster, probably because of some 
high-dose effect ofthe initiating 100 nmol DMBA. The initiation 
might also be the reason why the weight gain in the unrestricted 
group oftreatment B was slower than in treatment A. 1be weight 
curves for the control groups treated with acetone alone were 
not different from those seen with treatment A (data not shown). 
The cumulative skin-papilloma incidence is showo in Figure 2. 
Unexpectedly, diet restriction had no protective effect when the 
mice were treated chronically with DMBA (Figure 2A). Both 
time of onset of papilloma formation (13 weeks) and time of 50% 
cumulative incidence (t50 ; 17.5 and 18 weeks) were similar in 
both groups. A papilloma incidence of 100% was reacbed after 
25 and 28 weeks in unrestricted and restricted animals 
respectively. 
In contrast, and as expected from the literature (16), diet 
restriction bad a clearly proteelive effect in the initiation-
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Jila. 1. Body weightJ of male NMRI mice fed od libitum (opcn cin:les) or 
restricted to 70% feed in1akc (full circles). Treatment A (group size 81 statt 
30): 20 nmol DMBA twice wcddy, starting 81 weck 0. Treatment B (group 
size at start: 14): initiation wilh 100 nmol DMBA 81 week 0, followed by 
promotioo with 2., mnol TPA twice wcckly, .startin& 81 weck 1. Data are 
given as mcan weigbts : 1 SD. 
A 
- hJibllum 
- - - Reeltlc:l8d 
Flg. 2. Cumulative iDcideDce of skin papillomas in male NMRI mice fcd od 
libitllm (solid linc) or ~ to 70% feed intake (cWhed lioe). Treatment 
A: 20 nmol DMBA twice wccldy, starting 81 weck 0. Treatment 8: 
initiation with 100 nmol DMBA 81 week 0, followed by promotion wilh 2.S 
omol TP A twice wceldy, slartiog 81 week I. 
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promotion model (Figure 2B). The onset of papilloma fonnation 
increased from 7 to 11.5 weeks, the t50 was shifted from 8.5 
to 19 weeks. The papilloma incidence in the unrestricted group 
was 100% after 13 weeks and it would have taken much Ionger 
to resch 100% in the restricted group. Histological examination 
of the papillomas did not reveal any observable differences 
between tbe four groups. In the acetone control groups, no tumor 
was recorded within 28 weeks of observation. For controls treated 
only with DMBA (1 x 100 nmol) or TPA (10 nmol twice weekly), 
the papilloma incidence within 24 weeks bad been reported to 
be 0 or 4% (22). 
Our negative data are in contrast to Tannenbaum' s early 
findings mentioned above (1-4). The discrepancy could be due 
to the use of different carcinogens and different dose Ievels. The 
5 1'8 DMBA dose used here and tbe 60 ~ benzo[a]pyrene (B[a]P} 
dose used by Tannenbaum (1,3) can be considered equicarcino-
genic (25 ,26) but the relative importance of genotoxic versus 
promoting activity associated with the repeated administration 
of the two carcinogens could be different. For DMBA, 
carcinogenicity might be dominated by genotoxicity while the 
10-fold higher chemical dose of B[a]P could include a more 
pronounced 'promotional' activity. Such an explanation would 
also be in line with recent work by Birt and co-workers who 
showed that diet restriction bad a beneficial effect only when 
applied during tumor promotion but not during initiation (16). 
It could be argued that a dose of 20 nmol DMBA twice weekly 
was too high to allow restriction to come into play. The possibility 
that high doses of carcinogen could override the effects of diet 
restric:tion was mentioned by Tarmmbaum and Silverstone in tbeir 
review article ( 18). However, the dose used here did not result 
in a maximum rate of the process of carcinogenesis. While we 
observed a median latency time of 17.5 weeks, dose Ievels of 
25, 50 and 100 nmol resulted in tso values of 16, 12.5 and 11 
weeks respectively (24). Furthermore, the initiation-promotion 
protocol used in treatment B resulted in an even faster appearance 
of the papillomas in the unrestricted group and still allowed diet 
restriction to be protective. The question of whether diet 
restric:tion can retard the process of papilloma fonnation therefore 
strongly depends on the mechanism of action. It appears as if 
clonal expansion of initiated cells during tumor promotion could 
be reduced by diet restriction but that the rate of accumulation 
of critical mutations from chronic exposure to a genotoxic agent 
is not affected. 
Our results suggest that diet restriction is not proteelive under 
all circwnstances of chronic exposure to a carcinogen. Whether 
or not there is an effect depends upon the specific mechanism 
of carcinogenesis. Fora situation of chronic higb-dose exposure 
of mouse skin to a genotoxic agent the fonnation of papilloma 
could not be reduced. Although the datJl do not give any 
information on the process of tumor progression to carcinoma, 
they strongly indicate that diet restric:tion should not be considered 
a universal cancer-preventive measure. 
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